Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Soft-hard Technologies to Assistance and Accessibility in Patients With Chronic Diseases: The Effect of a Five Week Electrical Myostimulation Program.
Brief Summary: Patients afflicted with Chronic Heart Failure (HF) typically do not maintain stable cardiac function for the remainder of their life and consequently require continuous medical management and intermittent hospital admissions. Several investigations have demonstrated that electrical muscle stimulation (EMS) produces positive physiologic and psychological adaptations in patients with HF. However not all the EMS modalities were been evaluated on this population or not even were tested based on present recognized gold standard clinical parameters after a short period of treatment. The primary aims of the proposed study is to: Determine the effect of a five week home based of three EMS modalities on prognostics markers, perceived quality of life, muscle force and electrical activity in subjects diagnosed with HF.


Options:
A: Arm Label: No Treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Electrical Stimulation; Type: EXPERIMENTAL; Interventions: Device: Electrical Stimulation | Intervention Type: DEVICE; Name: Electrical Stimulation; Assigned to Arm(s): Electrical Stimulation
B: Arm Label: Functional electrical stimulation; Type: EXPERIMENTAL; Interventions: Procedure: Functional electrical stimulation | Arm Label: Medium-frequency alternating current; Type: EXPERIMENTAL; Interventions: Procedure: Medium-frequency alternating current | Arm Label: Burst-modulated alternating current; Type: EXPERIMENTAL; Interventions: Procedure: Burst-modulated alternating current | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Placebo | Intervention Type: PROCEDURE; Name: Medium-frequency alternating current; Assigned to Arm(s): Medium-frequency alternating current | Intervention Type: PROCEDURE; Name: Burst-modulated alternating current; Assigned to Arm(s): Burst-modulated alternating current | Intervention Type: PROCEDURE; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: PROCEDURE; Name: Functional electrical stimulation; Assigned to Arm(s): Functional electrical stimulation
C: Arm Label: NMES group; Type: EXPERIMENTAL; Interventions: Other: Neuromuscular electrical stimulation, Other: Endurance training, Other: Quadriceps strength training | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Other: Endurance training, Other: Quadriceps strength training | Intervention Type: OTHER; Name: Neuromuscular electrical stimulation; Assigned to Arm(s): NMES group | Intervention Type: OTHER; Name: Endurance training; Assigned to Arm(s): Control group, NMES group | Intervention Type: OTHER; Name: Quadriceps strength training; Assigned to Arm(s): Control group, NMES group
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Device: neuromuscular electrical stimulation: Cefar-Sport (CefarCompex Scandinavia AB) | Arm Label: B; Type: SHAM_COMPARATOR; Interventions: Device: neuromuscular electrical stimulation: Cefar-Sport (CefarCompex Scandinavia AB) | Intervention Type: DEVICE; Name: neuromuscular electrical stimulation: Cefar-Sport (CefarCompex Scandinavia AB); Assigned to Arm(s): A | Intervention Type: DEVICE; Name: neuromuscular electrical stimulation: Cefar-Sport (CefarCompex Scandinavia AB); Assigned to Arm(s): B

Answer: B